BioSpace News Archive

Drug Development

Medigene AG: Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers

Medigene AG announced that it has dosed the first patient in its first-in-human clinical trial with its TCR therapy candidate MDG1011.

February 26, 2019

·

6 min read

Business

Amidst FDA Rejection, Immunomedics’ CEO and President Steps Down

In addition to its fourth-quarter financial report, Morris Plains, NJ-based Immunomedics announced that its president, chief executive officer and board member, Michael Pehl, was stepping down for personal reasons.

February 26, 2019

·

2 min read

·

Mark Terry

Business

Top 5 Biotech Companies to Emerge From Bay Area Incubators

The San Francisco Business Times recently looked at top alumni from Bay Area incubators. Some of those companies are now brand-name companies like Uber and Reddit. Here’s a look at the biotech companies on their list.

February 26, 2019

·

2 min read

·

Mark Terry

Business

Genovis Year-end Report January – December 2018

Genovis has chosen to apply IFRS 16 in advance, as well as the simplification rule regarding short-term leases.

February 26, 2019

·

5 min read

Business

Actor Scott Foley and TESARO Team Up to Empower Ovarian Cancer Care Partners Through New Phase of Not on My Watch Movement

In a New Public Service Announcement, Foley Reveals for the First Time his Personal Story of Caring for his Mother Following Ovarian Cancer Recurrence

February 26, 2019

·

6 min read

Business

Retrophin Reports Fourth Quarter and Full Year 2018 Financial Results

Two pivotal Phase 3 studies of sparsentan progressing on-track to enable potential first-in-class treatment for both FSGS and IgAN

February 26, 2019

·

18 min read

Job Trends

Why a Common Antibiotic Treating Diarrhea is Failing

In the world of superbugs Clostridioides difficile, a bacterium that causes diarrhea and colitis, is among the most stubborn.

February 26, 2019

·

2 min read

How to Become a Top Performer When You Didn’t Get Enough Training

If you aren’t properly trained it can be very difficult to achieve successful results. Here’s how to become a top performer, even when you didn’t get enough training.

February 26, 2019

·

3 min read

·

Porschia Parker-Griffin

Pharm Country

Four Private Equity Women Investor Network (PEWIN) Members Raise a Total of $1.5 Billion for their Respective Funds

Members Adele Oliva (1315 Capital), Hollie Haynes (Luminate Capital Partners), Kristina Heinze (ParkerGale) and Kate Mitchell (Scale Venture Partners) have each successfully closed a new fund.

February 26, 2019

·

4 min read

Gain Therapeutics SA Announces Award of Grant Support from Leading Parkinson’s Research Foundations to Advance Its Proprietary Non Competitive Molecular Chaperones for Parkinson’s Disease

Gain Therapeutics SA announced that it has received funding support from The Michael J. Fox Foundation for Parkinson’s Research and The Silverstein Foundation for Parkinson’s with GBA to advance its proprietary non-competitive molecular chaperones for Parkinson’s disease.

February 26, 2019

·

4 min read